ALBALON Drug Patent Profile
✉ Email this page to a colleague
When do Albalon patents expire, and when can generic versions of Albalon launch?
Albalon is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in ALBALON is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALBALON?
- What are the global sales for ALBALON?
- What is Average Wholesale Price for ALBALON?
Summary for ALBALON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 91 |
| Patent Applications: | 1,963 |
| DailyMed Link: | ALBALON at DailyMed |
US Patents and Regulatory Information for ALBALON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | ALBALON | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 080248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
